Industry
Caristo Diagnostics Limited
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
Failure Rate
0.0%
0 terminated/withdrawn out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed trials have results
Key Signals
1 recruiting
Enrollment Performance
Analytics
N/A
1(100.0%)
1Total
N/A(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT06986733Not Yet Recruiting
Study of Management Alterations Resulting From CaRi-Heart® Technology in Patients Undergoing Coronary Computed Tomography Angiography (CCTA) for the Evaluation of Coronary Artery Disease: A United States Based Multi-Centre Study (SMART-CCTA-1)
Role: lead
NCT05058690Not ApplicableNot Yet Recruiting
Artificial Intelligence to Improve Cardiometabolic Risk Evaluation Using CT Scans
Role: lead
NCT05169333Recruiting
The Oxford Risk Factors And Non-Invasive Imaging Study
Role: collaborator
All 3 trials loaded